Ajay Kumar: Plasma Component Quality Control Standards
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“Blood centres are not just collection units, they are highly regulated manufacturing facilities operating under strict quality frameworks.
Different plasma components such as Fresh Frozen Plasma (FFP), Cryoprecipitate, and Cryo Poor Plasma are prepared through standardized processes that require precision, validated equipment, trained personnel, and robust documentation.
Each of these components must meet stringent quality control criteria as mandated by Directorate General of Health Services (DGHS) guidelines and Drugs and Cosmetics Act, 1940 and Rules, 1945.
Quality in transfusion medicine is not optional. It is regulatory, ethical, and lifesaving.”
Stay updated with Hemostasis Today.
-
Apr 13, 2026, 17:41Peter Zdziarski: Glanzmann’s Research Foundation Listed as GT Patient Organization on NORD
-
Apr 13, 2026, 17:39Nathan Connell: Why Prophylaxis in vWD Has Historically Lagged Behind Established Practice in Hemophilia
-
Apr 13, 2026, 17:38Tareq Abadl: A Blood Transfusion Can Cause a Delayed Platelet Crash
-
Apr 13, 2026, 13:33Tetsumei Urano: Join for the ISTH Educational Programs at APSTH 2026 in Japan
-
Apr 13, 2026, 13:26Salih Ehsan: Neutrophil Behavior Across Pregnancy and Infection Assessment
-
Apr 13, 2026, 13:20Denis Oduor: Autologous Blood Transfusion – A Significant Moment in Patient Care and Choice
-
Apr 13, 2026, 13:13Tareq Abadl: How the Immune System Turns Against the Body in Autoimmune Diseases
-
Apr 13, 2026, 13:13Yousra Tera: Celebrating a Lasting Impact on Future Generations
-
Apr 13, 2026, 13:07Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study